Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

8.3%

2 terminated out of 24 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

21%

5 trials in Phase 3/4

Results Transparency

40%

4 of 10 completed with results

Key Signals

4 with results83% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (15)
P 2 (2)
P 3 (4)
P 4 (1)

Trial Status

Completed10
Recruiting8
Unknown2
Terminated2
Enrolling By Invitation1
Not Yet Recruiting1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT07084831Phase 3RecruitingPrimary

A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia

NCT07165821Not ApplicableCompletedPrimary

Effects of an Interpersonal Communication Skills Training Program on Medication Adherence of Schizophrenic Patients

NCT05731414Not ApplicableRecruiting

Outcomes From Remediation and Behavioural Intervention Techniques

NCT05550155Not ApplicableRecruitingPrimary

Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations

NCT05763966RecruitingPrimary

Uppsala Psychosis Cohort

NCT06375902Enrolling By InvitationPrimary

The Fragility of Metaphors (FraMe): Learning, Loosing, and How to Train Them

NCT04738123Phase 3Completed

A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)

NCT06341517Not ApplicableRecruitingPrimary

Brain Circuitry Therapeutics for Schizophrenia

NCT06643871Not ApplicableNot Yet RecruitingPrimary

Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis

NCT06134661Not ApplicableTerminatedPrimary

Accelerated rTMS for Psychomotor Slowing

NCT04748679Not ApplicableCompletedPrimary

Cognitive Behavioral Therapy (CBT) Study Evaluating the Updating of Persecutory Beliefs

NCT06482554Phase 3Recruiting

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

NCT05445180Not ApplicableRecruiting

Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use

NCT04559529Phase 2CompletedPrimary

Pharmacological Modulation of Hippocampal Activity in Psychosis 2

NCT04853485Not ApplicableUnknownPrimary

Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes

NCT04659161Phase 3Completed

A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2)

NCT05995457Not ApplicableUnknownPrimary

The IM-ZBULLE Study : " Z-track " and " Airlock " Techniques During Intramuscular Injection of Haloperidol Decanoate

NCT05759091Not ApplicableCompletedPrimary

Effect of Applying Cognitive Defusion Techniques on Mindful Awareness, Cognitive Fusion and Believability of Delusions Among Clients With Schizophrenia

NCT04777266Not ApplicableCompletedPrimary

Music Therapy for People With Schizophrenia and Relates Psychosis.

NCT05858255Not ApplicableRecruitingPrimary

Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study

Scroll to load more

Research Network

Activity Timeline